Work

Novel TKI-resistant BCR-ABL1 gatekeeper residue mutations retain in vitro sensitivity to axitinib

Year: 2015

Type: article

Source: Leukemia

DOI: 10.1038/leu.2015.303

Authors: E A Lasater, E S Massi, A Stecula, J Politi, S K Tan, C C Smith, M Gunthorpe, J P Holmes, F Chehab, A Sali, N P Shah

Institutions: University of California, San Francisco, QB3, UCSF Helen Diller Family Comprehensive Cancer Center

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Award: Molecular and Cellular Mechanisms in Cancer

OpenAlex ID: W1822948265

FWCI:

Cites: 16

Cited by: 2

Related to: 10